The IPO Buzz: Obesity-Focused Kailera Therapeutics Sets $500 Million IPO
Kailera Therapeutics (KLRA Proposed), which is developing a weekly GLP-1 shot and a daily pill to help people lose weight, launched its $500 million IPO with an S-1/A filing early today – Monday, April 13, 2026. Kailera Therapeutics disclosed the terms – 33.33 million shares at a price range of $14.00 to $16.00 per share […]
April 13, 2026 Read More